جست‌وجوی استاد و پژوهشگر

• Gene Therapy
• Immunotherapy
• Immunobiology
• +۵ مورد دیگر

Associate Professor Grant Logan is a Senior Lecturer at the University of Sydney and a Research Scientist at the Children’s Medical Research Institute. He also serves as an Honorary Hospital Scientist at the Children’s Hospital at Westmead, where he develops serological tools to assess gene therapy eligibility. University of Sydney Children’s Medical Research Institute Children’s Hospital at Westmead Logan’s research focuses on the immunobiology of gene therapies using adeno-associated virus (AAV) vectors . His work explores host-vector interactions, pre-existing immunity, and strategies to enhance gene therapy efficacy for autoimmune and rheumatological disorders . He has contributed to understanding AAV vector tolerogenicity and immune modulation. Recent publications highlight his work on AAV vector engineering for liver-specific expression, DNaseI delivery in lupus models, and anti-AAV antibody characterization in spinal muscular atrophy patients. Honorary Hospital Scientist at Children’s Hospital at Westmead Member, Gene Therapy Technical Advisory Committee to Australian Office of the Gene Technology Regulator Collaborations with biotech industry and multiple patents Key grants include: 2024: NHMRC Ideas Grant for AAV bioengineering to escape pre-existing immunity 2022: NHMRC Ideas Grant for pharmaco-genetic autoimmune kidney disease treatment 2020: NHMRC Ideas Grant for anti-capsid immunity in SMA gene therapy

Denise Doolanمشاهده پروفایل

استاد

• Molecular Immunology
• Vaccinology
• Infectious Diseases
• +۵ مورد دیگر

Professor Denise Doolan is an Affiliate Professor in The University of Queensland's School of Chemistry and Molecular Biosciences and Deputy Director (Research) at the Institute for Molecular Bioscience (IMB). She previously served as Deputy Director of the Australian Institute of Tropical Health and Medicine and Director of the JCU Centre for Molecular Therapeutics. Her research focuses on molecular immunology, vaccine development, and omics-based approaches to combat infectious and chronic diseases, particularly malaria and Epstein-Barr virus (EBV)-related malignancies. She leads cross-disciplinary programs in antigen discovery, host-pathogen immunity, and biomarker development, leveraging genome-based technologies and human disease models. Academic Positions: Affiliate Professor, Deputy Director (IMB), Affiliate of Centre for Superbug Solutions Executive Roles: President of International Society for Vaccines (2021–2023), Member of Australian Medical Research Advisory Board Her research interests include vaccine engineering, systems immunology, and therapeutic development. Key projects involve identifying EBV protein signatures linked to Multiple Sclerosis and malaria immunity profiling using controlled human infection models. She is renowned for her work in malaria immunology and omics-based diagnostics, recognized with Fellowships from the International Society for Vaccines and Australian Society of Parasitology. Recent publications highlight her work on EBV antibody responses in lymphomas, malaria vaccine candidates, and molecular diagnostics for vascular diseases. She actively supervises PhD students in areas like EBV-MS links and malaria systems immunology, supported by grants from NIH, MS Research Australia, and ARC. Scientific Awards: ISV Fellowship (2017), ASP Fellowship (2019) Grants: NIH-funded malaria vaccine projects, EBV-MS diagnostics (MS Research Australia) Her lab collaborates on developing point-of-care tests and next-generation vaccines, emphasizing translational research to address global health challenges.

Paul Lehnerمشاهده پروفایل

استاد

• Immunology
• Virology
• Epigenetics
• +۶ مورد دیگر

Professor Paul Lehner holds the Sheila Joan Smith Professorship of Immunology at the University of Cambridge within the Department of Medicine (CITIID). As an active Infectious Diseases Physician, he bridges clinical practice with fundamental research in immunology and virology. His laboratory is situated at the Cambridge Biomedical Campus, contributing to the Cambridge Immunology Network as a Principal Investigator and clinician-scientist. Lehner's research program centers on virus-host interactions with particular emphasis on epigenetic mechanisms of viral silencing. His group's landmark discovery of the human silencing hub (HUSH) complex represents a major advance in understanding how cells defend against retroelement invasion through genome-wide surveillance. His work integrates proteomics, CRISPR screening, and advanced cell models to investigate antigen presentation, MHC biology, and immune regulation pathways. Recent investigations span from fundamental epigenetic mechanisms to translational applications including SARS-CoV-2 pathogenesis and Long Covid immunology. Analysis of his publication trajectory reveals consistent focus on viral immune evasion strategies, with growing emphasis on organoid models for respiratory diseases and novel host factors in viral entry mechanisms. His work demonstrates strong integration of basic molecular mechanisms with clinical immunology, particularly evident in recent studies on T cell responses in Long Covid and viral modulation of host proteostasis. Lehner's research program operates at the intersection of immunology, virology, and epigenetics, maintaining strong clinical connections through his Infectious Diseases practice. His laboratory employs cutting-edge techniques including CRISPR screening, advanced proteomics, and novel organoid models to investigate fundamental mechanisms of immune recognition and viral countermeasures.

Matthew S. Millerمشاهده پروفایل

دانشیار

• Infectious Diseases
• Viral Pandemics
• Vaccine Development
• +۵ مورد دیگر

Dr. Matthew S. Miller serves as Associate Professor in Biochemistry and Biomedical Sciences at McMaster University while holding leadership roles as Executive Director of the Global Nexus, Director of the Michael G. DeGroote Institute for Infectious Disease Research, and Co-Director of the Canadian Pandemic Preparedness Hub (CP2H). He maintains a Canada Research Chair in Viral Pandemics and sits on scientific advisory boards for major vaccine manufacturers. His research program integrates virology, immunology, and pandemic preparedness with emphases on SARS-CoV-2 and influenza pathogenesis. Key investigations include mucosal vaccine development, antibody response characterization across diverse populations, viral evolution mechanisms, and neurodegenerative consequences of viral infections. His work bridges fundamental virology with clinical applications through advanced platforms like DNA aptamer nanomaterials and inhaled aerosol vaccines. Recent publications demonstrate consistent focus on next-generation vaccine design against evolving pathogens, particularly examining immune responses in vulnerable populations including older adults and immunocompromised individuals. His team has pioneered respiratory mucosal delivery systems and high-precision viral detection methods using machine learning, directly addressing pandemic response challenges. Major scientific recognition includes: CIHR New Investigator Award CIHR Bhagirath Singh Early Career Award in Infection and Immunity Early Researcher Award from Government of Ontario Western University Distinguished Alumni Award for Excellence in Basic Science 2024 election to Royal Society of Canada College of New Scholars Dr. Miller actively recruits graduate students and postdoctoral fellows while leading multimillion-dollar initiatives funded through his Canada Research Chair and competitive grants. His national advisory roles include the Canadian National Advisory Committee on Immunization (NACI) COVID-19 Working Group, Committee to Advise on Tropical Medicine and Travel (CATMAT), and Public Health Agency of Canada's Expert Panel on Highly Pathogenic Avian Influenza. Previously, he served as Secretary-Treasurer of the Canadian Society for Virology (2021-2022). He directs three major collaborative entities—the Global Nexus, DeGroote Institute for Infectious Disease Research, and Canadian Pandemic Preparedness Hub—that integrate academic researchers, public health officials, and industry partners to accelerate pandemic countermeasure development through interdisciplinary teams spanning virology, immunology, and clinical medicine.

Jonathan Bohlenمشاهده پروفایل

پژوهشگر

• mRNA Translation
• Human Immunity
• Translational Regulation in T Cells
• +۶ مورد دیگر

Jonathan Bohlen serves as a Research Group Leader at the Gene Center, Ludwig Maximilian University of Munich (LMU), within the Department of Biochemistry. His laboratory focuses on mRNA translation mechanisms in human immunity, bridging molecular biology with clinical immunology to understand fundamental cellular processes. His educational background includes: Doctorate (2017-2020) at the German Cancer Research Center (DKFZ), Heidelberg M.Sc. in Molecular Biology (2015-2017) at Karls-Ruprecht University, Heidelberg B.Sc. in Biotechnology (2011-2015) at Hochschule Mannheim, Mannheim Dr. Bohlen's research centers on translational regulation in immune cells, with three primary focus areas: Translational Regulation in T Cells, Monogenic Ribosomopathies and Immunodeficiency, and tRNA Metabolism, Biogenesis, and Autoinflammatory Disease. His work explores how mRNA translation mechanisms affect leukocyte function and how disruptions in these processes lead to immunological disorders. By utilizing primary human leukocytes as a model system, his laboratory addresses the critical gap in understanding translational control in human physiology, which has been historically limited by the scarcity of live primary samples. Analysis of his recent publications reveals a consistent focus on the intersection of mRNA translation mechanisms and human immunity, particularly regarding IFN-γ responses to mycobacterial infections. His work demonstrates how specific translation factors (MCTS1, PRRC2) regulate critical immune proteins like JAK2, providing mechanistic insights into how translational defects lead to immunodeficiency. The publications span high-impact journals including Cell, Journal of Clinical Investigation, and Nucleic Acids Research, reflecting the significance of his contributions to understanding inborn errors of immunity through the lens of translational regulation. His scientific achievements have been recognized with prestigious awards: Marie Skłodowska-Curie Actions (MSCA) Postdoc Fellowship (2022) EMBO Postdoc Fellowship (2021) DFG Walter Benjamin Postdoc Stipendium (2021) RNA Society/Scaringe Graduate Student Award (2020) Dr. Bohlen actively mentors students and seeks motivated Master's students for internships and thesis projects focusing on molecular biology of mRNA translation. His laboratory aims to achieve three significant outcomes: enhanced understanding of ribosome and mRNA biology in leukocytes, insights into leukocyte involvement in genetic diseases of mRNA translation, and identification of pathomechanisms underlying severe genetic diseases. The research has direct clinical relevance to understanding and potentially treating immunological disorders with translational defects. The Bohlen Lab operates within the Gene Center Munich, a central scientific institution at LMU that fosters interdisciplinary research in genome biology, immunology, virology, and oncology. The lab's work exemplifies the institution's mission of advancing science beyond traditional disciplinary boundaries.

• Immunology
• Infectious Diseases
• Veterinary Medicine
• +۴ مورد دیگر

Prof. Dr. Victor Rutten serves as an Associate Professor in Infectious Diseases & Immunology at Utrecht University's Faculty of Veterinary Medicine, where he conducts research within the Department of Biomolecular Health Sciences. His academic profile demonstrates a sustained commitment to advancing veterinary immunology across multiple species and disease systems. Faculty position: Associate Professor in Infectious Diseases & Immunology Institutional affiliation: Faculty of Veterinary Medicine, Utrecht University Department: Department of Biomolecular Health Sciences Research focus: Immunology of infectious diseases in domestic and wild animals Dr. Rutten's research spans multiple domains of veterinary immunology. His work demonstrates particular expertise in elephant endotheliotropic herpesvirus (EEHV), canine autoimmune disorders, avian immunology, and mycobacterial diseases. His laboratory investigates immune mechanisms at cellular and molecular levels, with emphasis on antibody responses, cellular immunity, and host-pathogen interactions. The interdisciplinary nature of his research bridges basic immunological principles with practical veterinary applications. Analysis of Dr. Rutten's recent publications (2021-2025) reveals three dominant research themes. First, his extensive work on EEHV represents a significant contribution to wildlife conservation medicine, with multiple publications on antibody detection, vaccine development, and disease epidemiology in Asian elephants. Second, his research on polymyositis in Kooiker dogs has identified a specific 39 kb genomic deletion associated with this condition, advancing understanding of breed-specific autoimmune disorders. Third, his investigations into Leptospira immunology span vaccine development, TLR signaling, and cross-species immune responses, demonstrating translational potential for both veterinary and human medicine. Dr. Rutten actively supervises PhD students as indicated in his university profile, though specific student names aren't provided in the available information. His research appears well-funded, supporting multiple publication streams across different disease systems and animal species. The collaborative nature of his work is evident through extensive co-authorship with researchers both within Utrecht University and international institutions. While specific laboratory details aren't provided in the available information, Dr. Rutten's publication record suggests leadership in a multidisciplinary research team with expertise spanning immunology, virology, bacteriology, and molecular biology techniques. His work with both domestic animals (dogs, chickens) and wildlife (elephants) reflects a comprehensive approach that bridges clinical veterinary medicine and conservation biology.

• Immunology
• Virology
• Aging
• +۸ مورد دیگر

Ruth R. Montgomery is a Professor of Medicine and Epidemiology at Yale School of Medicine and Yale School of Public Health , with a secondary appointment in Pathology . As Associate Dean for Scientific Affairs , she leads institutional research initiatives. Director, Yale CyTOF Facility (since 2013) Co-Chair, University Provost’s ITS Advisory Committee Principal Investigator, IMPACC Study on hospitalized COVID-19 patients Research Focus: Cellular immunology with emphasis on age-related immune dysregulation , innate immunity , and human translational studies of viral infections (West Nile, Dengue, Zika, SARS-CoV-2). Key methodologies include single-cell mass cytometry and multi-omics profiling . Scientific Contributions: 2025 AAAS Fellow; pioneer in aging-immunity interactions; identified CD16 polymorphisms reducing severe COVID-19 risk; discovered ELF4 deficiency as a monogenic mimic of Behçet's syndrome. Article Trends: Recent work spans age-dependent immune signatures in viral pathogenesis, multi-omics modeling of severe infections, and therapeutic immune monitoring in mepolizumab-treated populations. Collaborations span Yale Center for Research on Aging , Human and Translational Immunology Program , and Yale-BI Biomedical Data Science Fellowship . Honors: Fellow, American Association for the Advancement of Science (2025) Member, Connecticut Academy of Science and Engineering (2020) Key Collaborations: Frequent co-authorships with Erol Fikrig , Albert C. Shaw , Steven Kleinstein , and David Hafler across 161 publications. Faculty leadership roles in Chronic Disease Epidemiology and Public Health Data Science initiatives.

Ravi Kantمشاهده پروفایل

دانشیار مدعو

• Virology
• Zoonotic Diseases
• Infectious Diseases
• +۵ مورد دیگر

Ravi Kant serves as Principal Investigator and Adjunct Associate Professor at the University of Helsinki, with additional Visiting Professor appointments at Medical University of Gdansk, Poland and University of Nairobi, Kenya. He is affiliated with the Helsinki One Health (HOH) Viral Zoonosis Research Unit and the Emerging Infections Research Group within the Department of Virology at the Faculty of Medicine. His research focuses on viral zoonoses, emerging infectious diseases, and viral genomics. Key research areas include SARS-CoV-2 transmission dynamics, viral pathogenesis in animal models, viral metagenomics, and molecular epidemiology of emerging pathogens. His work spans both human and veterinary medicine, reflecting the One Health approach that characterizes his research unit. Kant leads multiple significant research projects including the EU-funded REFINE project (2025-2028), Pipeline for Rapid Diagnostics of Emergency Transboundary Infectious Diseases (2023-2027), and research on poxvirus epidemiology and disease control (2022-2025). His publication record demonstrates consistent output with 81 publications spanning from 2005 to 2025, with recent emphasis on SARS-CoV-2, mpox, antimicrobial resistance, and viral metagenomics. He actively supervises doctoral students across multiple programs including Biomedicine, Microbiology and Biotechnology, and Clinical Veterinary Medicine, with several ongoing doctoral supervision activities documented through 2025. His media engagement includes significant contributions to public understanding of infectious diseases, with appearances discussing topics such as the cause of dermatitis epidemics in trotting horses, innovative mobile diagnostic laboratories, and mitochondrial roles in antiviral immunity.

Andrea A. Berryمشاهده پروفایل

دانشیار

• Malaria Immunology
• Pediatric Vaccine Trials
• Clinical Vaccine Studies
• +۳ مورد دیگر

Dr. Andrea A. Berry is an Associate Professor in Pediatrics at the University of Maryland School of Medicine, with a secondary appointment in Medicine. She specializes in pediatric infectious diseases and malaria immunology, leading the Malaria Immunology Unit within the Malaria Research Program at the University of Maryland Center for Vaccine Development and Global Health (CVD). Her work focuses on the humoral immune response to malaria and clinical vaccine trials, including studies on SARS-CoV-2, influenza, and rotavirus vaccines. Education: Columbia College (B.A., Biochemistry, 1998), University of Pennsylvania School of Medicine (M.D., 2003), University of Maryland (M.S., Epidemiology and Clinical Research, 2023). Completed pediatrics residency at The Children's Hospital of Philadelphia (2003–2006) and a pediatric infectious diseases fellowship at the University of Maryland School of Medicine (2006–2009). Research interests include malaria vaccine development, antibody response dynamics to vaccines, and controlled human malaria infection studies. Her group explores pre-erythrocytic immune responses and vaccine candidate evaluation. Recent studies addressed SARS-CoV-2 antibody persistence, vaccine acceptance factors, and malaria immunoproteomics. Key awards include the 2016 Passano Foundation Clinician-Investigator Award. She is active in professional societies such as the American Academy of Pediatrics and the Infectious Disease Society of America. Dr. Berry contributes to clinical trials, public health advisory committees (Baltimore schools), and media outreach on infectious diseases and vaccines.

Pilar Alcaideمشاهده پروفایل

استاد

• Immunology
• Cardiac Physiology
• Vascular Biology
• +۴ مورد دیگر

Pilar Alcaide is a Professor of Immunology at Tufts University School of Medicine. Her research focuses on understanding molecular mechanisms of T lymphocyte trafficking in inflammatory heart diseases, particularly heart failure. She combines immunology, vascular biology, and cardiac physiology to investigate immune-cardiac interactions using mouse models and advanced microscopy techniques. Education: Ph.D. and M.S. in Immunology from Universidad Autónoma de Madrid (Spain) Dr. Alcaide's lab explores how T cell-endothelial interactions contribute to cardiac pathophysiology, with translational goals toward developing immune-based therapeutics. Key areas include: STING signaling in microglial-neuronal interactions Myeloid fatty acid metabolism in HFpEF CXCR3 blockade for immunotherapy myocarditis Her work has been funded by NIH grants (e.g., mechanisms of T cell activation in cardiac fibrosis). Notable awards include the ASIP Cotran Early Career Investigator Award.

Deborah Dunn-Waltersمشاهده پروفایل

استاد

• Immunology
• B Cell Biology
• Immunosenescence
• +۴ مورد دیگر

Deborah Dunn-Walters is a Professor of Immunology and Associate Dean for Research and Innovation at the University of Surrey. She leads the Department of Biochemistry and Physiology within the School of Biosciences, Faculty of Health and Medical Sciences. Her research focuses on B cell development, immunosenescence, and antibody repertoire dynamics, with particular emphasis on responses to SARS-CoV-2 and other respiratory infections. Dunn-Walters pioneered tools like BRepertoire and sciCSR for analyzing immune repertoires using single-cell and computational methods. She chairs international B cell conferences and collaborates globally. Education includes a BSc (Hons I) and PhD, details unspecified. Her work integrates systems immunology approaches to understand age-related changes in humoral immunity, aiming to improve vaccine efficacy and combat pandemic threats. Awards include Fellowship of the Academy of Medical Sciences (2025). Research interests span regulatory B cells, metabolic regulation (e.g., thioredoxin’s role), tumor-infiltrating B lymphocytes, and antibody diversity in health/disease. She leads a lab developing novel methods for immune repertoire analysis, including web tools like VCAb for antibody structure exploration. Grants and advising are central to her role as Associate Dean, though specific grants aren’t listed. She oversees research innovation strategies and supports interdisciplinary collaborations. Her lab’s work has implications for cancer immunology, autoimmune disease, and infectious disease management.

• Respiratory Immunology
• Clinical Sciences
• Immunology
• +۳ مورد دیگر

Dr. Ryan Thwaites is an Assistant Professor in Respiratory Immunology at the National Heart & Lung Institute (NHLI), part of Imperial College London's Faculty of Medicine. His research focuses on the immune mechanisms governing respiratory viral infections, particularly Respiratory Syncytial Virus (RSV), influenza, and SARS-CoV-2. He leads the Thwaites Lab Group, which develops non-invasive sampling techniques (e.g., nasosorption) to study viral infections in children and adults. Thwaites holds a PhD in innate immunology from the Brighton and Sussex Medical School (2015) and completed postdoctoral work at NHLI under Professors Peter Openshaw and Trevor Hansel. His work during the SARS-CoV-2 pandemic contributed to understanding immune responses in severe cases and vaccine efficacy through the ISARIC4C consortium. Research themes include viral pathogenesis, biomarker discovery, and immune correlates of protection. His team investigates neutrophil roles in respiratory infections, microbiome dynamics, and long-term sequelae of viral illnesses (e.g., Long-COVID). Thwaites collaborates internationally on multi-omic studies, genetic susceptibility analyses, and clinical trials. He has advised on pandemic preparedness and contributed to global guidelines for respiratory virus management. Labs/Teams: Thwaites Lab Group (NHLI, Imperial College London).

• Immunology
• Cellular Immunity
• B Cell and Antibody Responses
• +۱۸ مورد دیگر

Philip Askenase is Professor of Medicine in the Department of Internal Medicine at Yale School of Medicine, with a focus on Immunology. He is affiliated with the Cancer Immunology program, the Center for Brain & Mind Health, and the Center for RNA Science and Medicine at Yale. Research Interests: Immunochemistry and cellular immunity B-1 B cell functions in T cell immunity Regulatory T cells and antigen-specific suppression Exosome-mediated transfer of miRNA (e.g., miRNA-150) in immune regulation Applications in allergy, autoimmunity, cancer, and spinal cord injury Development of exosome-based diagnostics (liquid biopsy) and therapeutics His recent publications highlight the role of extracellular vesicles in psychiatric conditions, pandemic prevention through chromatin vaccines, and systems vaccinology in HIV. These works reveal a strong trend toward interdisciplinary research bridging immunology, neuroscience, and regenerative medicine, with a focus on novel therapeutic delivery systems using exosomes. Scientific Awards: Legends of Allergy and Immunology (Wiley Online Library, 2023) Dr. Askenase has mentored numerous researchers and collaborators, though specific student names are not listed. His work has been supported by extensive research funding, particularly in immunology and exosome biology. He has contributed to major advances in understanding exosome carrier effects and their resistance to phagolysosomal digestion, which enhances targeted delivery. He is a key member of collaborative teams including the Yale Center for RNA Science and Medicine and the Cancer Immunology initiative. His lab investigates how exosomes from mesenchymal stem cells promote functional recovery in spinal cord injury through modulation of macrophage phenotypes and microvascular stabilization.

Emanuelle A Bellaguardaمشاهده پروفایل

استادیار

• Inflammatory Bowel Disease (IBD)
• Gastroenterology
• Therapeutic Drug Monitoring
• +۳ مورد دیگر

Emanuelle A Bellaguarda, MD is an Assistant Professor of Medicine in the Gastroenterology and Hepatology Division at the Feinberg School of Medicine, Northwestern University . Her clinical and research focus includes Inflammatory Bowel Disease (IBD) , Therapeutic Drug Monitoring , and Clinical Trials . Education: MD from Federal University of Ceara, Brazil (2006); Residency in Internal Medicine at Boston University Medical Center (2011); Fellowships in Gastroenterology/Hepatology at University of Chicago (2014) and Inflammation research at Northwestern University (2015). Her research examines IBD pathophysiology , immune responses to vaccines in IBD patients , and biologic therapies (e.g., tofacitinib, ustekinumab). She has published extensively on COVID-19 vaccination efficacy in IBD populations and male fertility outcomes with immunomodulatory drugs. Her recent work highlights long-term immunity post-vaccination in pediatric and adult IBD cohorts, drug safety profiles (e.g., methotrexate, ustekinumab), and emotional health disparities in IBD. She serves on Scientific and Medical Advisory Boards for companies like Abbvie, Pfizer, and the Crohn's & Colitis Foundation.

Kim Jacobsonمشاهده پروفایل

استاد

• Immunology
• B cell memory
• Epigenomics
• +۳ مورد دیگر

Professor Kim Jacobson is a Professor (Research) in the Department of Biochemistry and Molecular Biology at Monash University , Australia, and leads the B cells, Antibody, Memory Laboratory within the Monash Biomedicine Discovery Institute . She is a NHMRC Investigator Fellow and Bellberry-Viertel Senior Medical Research Fellow , recognized for her groundbreaking work in immunology and epigenetics. Education: PhD, Centenary Institute and Garvan Institute of Medical Research (2007) Postdoctoral training, Yale University (NHMRC CJ Martin Fellowship) Research Interests: Professor Jacobson's research focuses on understanding the molecular and epigenetic mechanisms underlying the formation of immune memory. Her lab investigates how chromatin modifications and transcriptional programs regulate B cell differentiation, memory formation, and antibody responses, particularly in the context of chronic infectious diseases and vaccine development. Scientific Awards: Victorian Young Tall Poppy Science Award (2016) Monash University Vice-Chancellor’s Diversity and Inclusion Award (2017) Advising & Grants: She currently supervises several PhD students and has received substantial funding from the NHMRC, ARC, MRFF, Cancer Institute NSW, and Leukaemia Foundation of Australia. Her projects span from epigenetic regulation of humoral immunity to AI-driven identification of post-acute sequelae of SARS-CoV-2 (PASC). Laboratory & Team: The Jacobson Lab is part of the Immunity Program at Monash Biomedicine Discovery Institute. The team includes postdoctoral researchers and graduate students working collaboratively on cutting-edge immunological research using advanced techniques like single-cell RNA-seq, ATAC-seq, and CRISPR-based epigenome editing.